Table 1.
Mean age, years of education, years since diagnosis, UPDRS score, and duration (in months) since implantation for participant groups: PD-DBS, PD (without DBS), and HC.
| PD with DBS (n = 6) | PD without DBS (n = 7) | Total PD (n = 13) | HC (n = 14) | ||
|---|---|---|---|---|---|
| Age | 58.17 (range: 49–62) | 63.14 (range: 44–73) | 60.85 (range: 44–73) | 55.50 (range: 36–72) | |
| Education | 16.17 (SD = 1.60) | 15.86 (SD = 2.12) | 16.00 (SD = 1.83) | 16.00 (n = 13) (SD = 1.87) | |
| Years since diagnosis | 12.67 (SD = 3.45) | 10.29 (SD = 3.09) | 11.38 (SD = 3.36) | – | |
| UPDRS score | Off 27.83 (SD = 13.65) |
On 18.08 (SD = 9.95) |
20.50 (SD = 6.63) | 23.88 (SD = 10.68) | – |
| Duration of DBS (months) | 17.00 (SD = 22.11) | – | – | ||
| Levadopa dosage (mg) | 516.67 (n = 6, SD = 132.92) | 550.00 (n = 2, SD = 212.13) | – | ||